Evidence map›Paper›PMID 40878353›Full record

ArticleMuscle & nerve2025

Three-Dimensional Magnetic Resonance Imaging of Median Nerve Volume for Assessing Carpal Tunnel Syndrome Severity.

Kazuki Hayakawa, Taku Suzuki, Katsuhiko Hayakawa, Yusuke Kawano, Takuji Iwamoto, Nobuyuki Fujita

Abstract read
In one paragraph

Article in Muscle & nerve, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kazuki HayakawaDepartment of Orthopaedic Surgery, Fujita Health University, Toyoake, Japan.
Taku SuzukiDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2312-3540
Katsuhiko HayakawaAiko Orthopaedic Surgery Hospital, Nagoya, Japan.
Yusuke KawanoDepartment of Orthopaedic Surgery, Fujita Health University, Toyoake, Japan.
Takuji IwamotoDepartment of Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan.
Nobuyuki FujitaDepartment of Orthopaedic Surgery, Fujita Health University, Toyoake, Japan.ORCID https://orcid.org/0000-0001-8658-2088

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION/

aims3D magnetic resonance imaging (MRI) is a tool for visualizing and quantifying the volume of the median nerve; however, the diagnostic value of the volume of the median nerve for assessing CTS severity is unclear. This study aimed to evaluate the utility of 3T MRI combined with three-dimensional (3D) imaging to assess the cross-sectional volume (CSV) of the median nerve for diagnosing carpal tunnel syndrome (CTS) and determining its severity.

methodsWe used MRI to measure the CSV of the median nerve in 95 patients with CTS and 26 healthy controls. CTS severity was graded according to the Padua classification, and differences in CSV according to severity were analyzed.

resultsThe mean CSVs for the severity groups were as follows: control, 22.4 mm DISCUSSION: This study showed that the CSV of the median nerve increased with disease severity, both visually and in three dimensions. This helps to visually understand the severity of CTS, and the association between morphology and disease severity may contribute to a better understanding of the pathophysiology of CTS.

Indexed as

Carpal Tunnel SyndromeImaging, Three-DimensionalMagnetic Resonance ImagingMedian NerveAdultAgedFemaleHumansMaleMiddle AgedSeverity of Illness Indexcarpal tunnel syndromecross‐sectional volumemagnetic resonance imagingmedian nerveseveritythree‐dimensional MRI

Identifiers

PMID40878353
PMCPMC12529045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.